Gardiner Healthcare Acquisitions Corp.
Liquidated 2023-12-11- CIK 1858912
- GDNR
- IPO 2021-12-22
- $20.3M trust
- 93 filings
- IPO Size
- $86.3M
- raised at the IPO
- Trust
- $20.3M
- as of 2023-03-31
- Current Status
- Failed
- from its latest filing
- IPO Year
- 2021
- year it listed
Filings, by quarter
93 filings over 12 quarters; violet bars carry a milestone
- 21 Q2: 2 filings
- 21 Q3: 0 filings
- 21 Q4: 31 filings
- 22 Q1: 8 filings
- 22 Q2: 2 filings
- 22 Q3: 1 filing
- 22 Q4: 7 filings
- 23 Q1: 6 filings
- 23 Q2: 9 filings
- 23 Q3: 19 filings
- 23 Q4: 5 filings
- 24 Q1: 3 filings
S-1 filed
IPO
Liquidated
- S-1 filed 21 Q2
- IPO 21 Q4
- Liquidated 23 Q4
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
Gardiner Healthcare Acquisitions Corp. is a blank-check company seeking a business combination, with a stated focus on healthcare-related businesses, particularly North American or European life sciences and medical technology companies, including small- and large-molecule therapeutics.
Investment Focus
Healthcare, Biopharmaceuticals
Geographic Focus
North America, Europe
Key Information
As the filings state it
- IPO Date
- 2021-12-22
- Total Redemptions
- $3.5M
- Jurisdiction of Incorporation
- Delaware
- SIC
- 6770
- Failed Date
- 2023-12-11
- SPAC Ticker
- GDNR
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
The management and co-sponsor team has life sciences operating, investment and pharmaceutical experience, including clinical development, biotech company building, healthcare investment banking and SPAC sponsorship.